Literature DB >> 29231582

[Strategy programming for acupuncture development along One-Belt-One-Road countries].

Yuyang Yang1,2, Zhixiang Shen2, Zhongchao Wu3, Lu Luo1,2, Jingyuan Liu2, Baoyan Liu1,2.   

Abstract

Acupuncture has been applied in 183 countries and regions and gradually become a name card as TCM spreads across the world. The international influence of which plays a significant role in enhancing TCM development. The laws and regulations of TCM acupuncture along One-Belt-One-Road countries were compared and analyzed in this article. With comprehensive research and analysis, the international development strategy of acupuncture was rationally proposed. Combined with the historical background of China's national initiative One-Belt-One-Road, the acupuncture was taken as a breakthrough to lead the global spreading of TCM culture and Chinese herbs, so as to enhance China's soft strength, which could further create a fine cultural environment for the economic prosperity of One-Belt-One-Road countries. In addition, the strategy selection for China regarding TCM acupuncture development along One-Belt-One-Road countries was proposed, and the suggestive solution and implementation strategy for the essential missions and significant issues were provided.

Keywords:  One-Belt-One-Road; acupuncture; development strategy

Mesh:

Year:  2017        PMID: 29231582     DOI: 10.13703/j.0255-2930.2017.04.001

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

1.  The intentions, needs, advantages and barriers: a survey of twenty-nine countries participating in the "Belt and Road Initiative" health cooperation.

Authors:  Yao Wang; Xiaohui Liang; Yuchen Liu; Yuanan Lu; Xiaojun Liu; Zongfu Mao
Journal:  Glob Health Res Policy       Date:  2019-06-28

2.  Effect of acupuncture versus artificial tears for dry eye disease: A protocol for systematic review and meta-analysis.

Authors:  Hongjuan Fu; Junxiang Wang; Feng Zhang; Yong Tang; Hao Zhou; Chao Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.